Behavioural and cardiovascular effects of medetomidine constant rate infusion compared with detomidine for standing sedation in horses.
Abstract: To compare the efficacy of a medetomidine constant rate infusion (CRI) with a detomidine CRI for standing sedation in horses undergoing high dose rate brachytherapy. Methods: Randomized, controlled, crossover, blinded clinical trial. Methods: A total of 50 horses with owner consent, excluding stallions. Methods: Each horse was sedated with intravenous acepromazine (0.02 mg kg-1), followed by an α2-adrenoceptor agonist 30 minutes later and then by butorphanol (0.1 mg kg-1) 5 minutes later. A CRI of the same α2-adrenoceptor agonist was started 10 minutes after butorphanol administration and maintained for the treatment duration. Treatments were given 1 week apart. Each horse was sedated with detomidine (bolus dose, 10 μg kg-1; CRI, 6 μg kg-1 hour-1) or medetomidine (bolus dose, 5 μg kg-1; CRI, 3.5 μg kg-1 hour-1). If sedation was inadequate, a quarter of the initial bolus of the α2-adrenoceptor agonist was administered. Heart rate (HR) was measured via electrocardiography, and sedation and behaviour evaluated using a previously published scale. Between treatments, behaviour scores were compared using a Wilcoxon signed-rank test, frequencies of arrhythmias with chi-square tests, and HR with two-tailed paired t tests. A p value <0.05 indicated statistical significance. Results: Total treatment time for medetomidine was longer than that for detomidine (p = 0.04), and ear movements during medetomidine sedation were more numerous than those during detomidine sedation (p = 0.03), suggesting there may be a subtle difference in the depth of sedation. No significant differences in HR were found between treatments (p ≥ 0.09). Several horses had arrhythmias, with no difference in their frequency between the two infusions. Conclusions: Medetomidine at this dose rate may produce less sedation than detomidine. Further studies are required to evaluate any clinical advantages to either drug, or whether a different CRI may be more appropriate.
Copyright © 2019 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.
Publication Date: 2019-09-03 PubMed ID: 31619335DOI: 10.1016/j.vaa.2019.06.009Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Randomized Controlled Trial
- Veterinary
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research compared the effectiveness of medetomidine and detomidine for standing sedation in horses undergoing high dose rate brachytherapy. The study revealed that medetomidine may produce less sedation than detomidine, but further studies are required to evaluate any clinical advantages between the two drugs.
Introduction
- This scientific study was a randomized, controlled, crossover, blinded clinical trial involving 50 horses. The horses were given standing sedation and were undergoing high dose rate brachytherapy.
- The main goal of this research was to compare the efficacy of medetomidine and detomidine, both of which were administered as constant rate infusions (CRI).
Procedure
- Each horse was sedated with acepromazine followed by an α-adrenoceptor agonist and then by butorphanol. A CRI of the α-adrenoceptor agonist was started 10 minutes after administering butorphanol and maintained throughout the treatment duration.
- Each horse was sedated using either detomidine or medetomidine. If the sedation was found to be inadequate, a quarter of the initial bolus of the α-adrenoceptor agonist was administered.
- The heart rate of each horse was measured using electrocardiography, and the horse’s behaviour and sedation levels were evaluated using a previously published scale.
- The treatments were given a week apart and the findings compared using statistical methods including Wilcoxon signed-rank test, chi-square tests, and two-tailed paired t tests.
Results
- The medetomidine treatment time was longer than that for detomidine, potentially suggesting a difference in depth of sedation. Additionally, ear movements which can indicate discomfort, were observed to be more frequent during medetomidine sedation.
- However, no significant differences in heart rate between the two treatments were found.
- There were several cases of arrhythmias observed in the horses undergoing the treatment but no difference in their frequency between the two infusions.
Conclusion
- In conclusion, this study finds that medetomidine may provide a lesser degree of sedation than detomidine.
- Further research is needed to assess the clinical advantages of each drug and to identify if there could be a more suitable constant rate infusion drug for sedating horses.
Cite This Article
APA
Hollis AR, Pascal M, Van Dijk J, Jolliffe C, Kaartinen J.
(2019).
Behavioural and cardiovascular effects of medetomidine constant rate infusion compared with detomidine for standing sedation in horses.
Vet Anaesth Analg, 47(1), 76-81.
https://doi.org/10.1016/j.vaa.2019.06.009 Publication
Researcher Affiliations
- Animal Health Trust, Lanwades Park, Kentford, UK. Electronic address: anna.hollis@aht.org.uk.
- Animal Health Trust, Lanwades Park, Kentford, UK.
- Animal Health Trust, Lanwades Park, Kentford, UK.
- Animal Health Trust, Lanwades Park, Kentford, UK.
- Animal Health Trust, Lanwades Park, Kentford, UK.
MeSH Terms
- Anesthesia / veterinary
- Animals
- Behavior, Animal / drug effects
- Brachytherapy / veterinary
- Cross-Over Studies
- Female
- Heart Rate / drug effects
- Horses
- Hypnotics and Sedatives / administration & dosage
- Hypnotics and Sedatives / pharmacokinetics
- Hypnotics and Sedatives / therapeutic use
- Imidazoles / administration & dosage
- Imidazoles / pharmacology
- Imidazoles / therapeutic use
- Infusions, Intravenous / veterinary
- Male
- Medetomidine / administration & dosage
- Medetomidine / pharmacology
- Medetomidine / therapeutic use
- Single-Blind Method
- Standing Position
- Treatment Outcome
Citations
This article has been cited 1 times.- Tomsits P, Volz L, Xia R, Chivukula A, Schüttler D, Clauß S. Medetomidine/midazolam/fentanyl narcosis alters cardiac autonomic tone leading to conduction disorders and arrhythmias in mice. Lab Anim (NY) 2023 Apr;52(4):85-92.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists